Poland· PL-100510790

Dostinex

A cabergoline product containing cabergolinum, registered in Poland by Allpharm Sp. z o.o. sp.k.. The same ATC class is registered in 13 of our 19 countries.

ATC G02CB03

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cabergolinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cabergoline is registered in 13 of 19 countries.

Countries holding a registration under ATC G02CB03 (cabergoline), each read from that country’s own register.

This record: Poland, from URPL (Poland)
8 of them publish a price we can compare per daily dose

Search cabergoline products by name

Cabergoline · ATC G02CB03

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cabergoline costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), the median price runs from $4.08 in Italy to $11.81 in Switzerland — a ×2.9 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cabergoline · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

CH Switzerland$11.81
IT Italy$4.08

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Cabergolinum
Manufacturer: Allpharm Sp. z o.o. sp.k.
Country: Poland (PL)
ATC code: G02CB03
ATC class: Cabergoline
Defined daily dose: 0.5 mg, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 2

gtin
05909991562144
gtin
05909991562151

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

65 interactions on record for cabergoline.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cabergoline against other medicines How interaction checks work

Cabergoline · interactions on record

65 records

3 severe
17 moderate
45 info

Most severe, free to view

LorcaserinA08AA11severe
ErythromycinJ01FA01severe
ClarithromycinJ01FA09severe
MetoclopramideA03FA01moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cabergoline in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cabergoline products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Cabaseril, Dostinex
Belgium · Cabergoline Teva, Dostinex
Bulgaria · Достинекс
Cyprus · Dostinex
Czechia · Dostinex
Germany · Cabaseril, Cabergoletten
Denmark · Cabenex, Cabergolin Teva
Spain · Cabergolina Teva, Dostinex
Finland · Cabaser, Dostinex
France · Cabergoline Arrow, Cabergoline Biogaran
United Kingdom (Northern Ireland) · Cabaser, Cabergoline Aspire Pharma
Greece · Dostinex
Croatia · Dostinex
Ireland · Cabaser, Cabergoline Renata Pharmaceuticals (Ireland)
Iceland · Dostinex
Italy · Cabaser, Cabergolina Aurobindo
Luxembourg · Cabergoline Teva, Dostinex
Latvia · Dostinex
Malta · Cabergoline Aurobindo, Cabergoline Doc
Netherlands · Cabergoline Aurobindo, Cabergoline Pch
Norway · Cabergoline Renata Pharmaceuticals (Ireland), Dostinex
Portugal · Cabergolina Generis, Cabergoline 0.5 Mg Tablets
Romania · Dostinex
Sweden · Cabenex, Cabergoline Ratiopharm
Slovakia · Cabest

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/33e8c7d4-6904-44ef-a08e-d4357fa1d244
GET /v1/drugs/33e8c7d4-6904-44ef-a08e-d4357fa1d244?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "0,5 mg",
  "packaging": "05909991562144 ¦ Rp ¦ 159695\n8 tabl.\n05909991562151 ¦ Rp ¦ 159696\n2 tabl.",
  "substance": "Cabergolinum 0.5 mg",
  "common_name": "Cabergolinum",
  "pl_product_id": "100510790",
  "pozwolenie_nr": "002/25",
  "auth_procedure": "IR",
  "authorisation_validity": "2030-01-09"
}

API reference MCP server Plans

See everything about cabergoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console